Validation of the enhanced liver fibrosis (ELF)-test in heparinized and EDTA plasma for use in reflex testing algorithms for metabolic dysfunction-associated steatotic liver disease (MASLD)

被引:0
|
作者
van Son, Koen C. [1 ,2 ,3 ]
van Dijk, Anne-Marieke [1 ,2 ]
Driessen, Stan [1 ,2 ]
Mak, Anne Linde [1 ]
Witjes, Julia J. [1 ]
Houttu, Veera A. T. [1 ]
Zwirs, Diona [1 ]
Nieuwdorp, Max [1 ]
van den Born, Bert-Jan H. [1 ,4 ]
Fischer, Johan C. [5 ]
Tushuizen, Maarten E. [6 ]
Drenth, Joost P. H. [3 ]
Hamer, Henrike M. [5 ]
Beuers, Ulrich H. W. [3 ]
Verheij, Joanne [2 ,7 ]
Holleboom, Adriaan Georgius [1 ]
机构
[1] Amsterdam UMC, Locat AMC, Dept Vasc Med, Meibergdreef 9, Amsterdam, Netherlands
[2] Amsterdam Gastroenterol Endocrinol Metab AGEM Inst, Amsterdam UMC, Locat AMC, Amsterdam, Netherlands
[3] Amsterdam UMC, Dept Gastroenterol & Hepatol, Locat AMC, Meibergdreef 9, Amsterdam, Netherlands
[4] Dept Publ & Occupat Hlth, Amsterdam UMC, Locat AMC, Amsterdam, Netherlands
[5] Univ Amsterdam, Dept Lab Med, Lab Specialized Diagnost & Res, Amsterdam UMC, Amsterdam, Netherlands
[6] Dept Gastroenterol & Hepatol, LUMC, Leiden, Netherlands
[7] Amsterdam UMC, Locat AMC, Dept Pathol, Amsterdam, Netherlands
关键词
metabolic dysfunction-associated steatotic liver disease (MASLD); advanced liver fibrosis; enhanced liver fibrosis (ELF)-test; reflex testing; diagnostic algorithms;
D O I
10.1515/cclm-2024-0470
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
引用
收藏
页码:e236 / e239
页数:4
相关论文
共 50 条
  • [41] Liver Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease is Independently Associated with Reduced Kidney Function
    Karim, Gres
    Villarroel, Carolina
    Giri, Dewan
    Weisberg, Ilan
    Dinani, Amreen
    JOURNAL OF HEPATOLOGY, 2024, 80 : S487 - S487
  • [42] Limitations of FIB-4 Score in Excluding Advanced Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
    Bentley, Blake
    Ventura, Frank
    Obermmiller, Corey
    Russo, Mark
    Rudnick, Sean
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1380 - S1380
  • [43] Genome-wide Association Study on Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)
    Darlay, Rebecca
    Zatorska, Michalina
    Worthington, Sarah
    Anstee, Quentin M.
    Daly, Ann K.
    Cordell, Heather J.
    GENETIC EPIDEMIOLOGY, 2024, 48 (07) : 352 - 352
  • [44] ENHANCING TRADITIONAL FIBROSIS PREDICTION MODELS WITH MACHINE LEARNING IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)
    Kim, David
    Qureshi, Imran
    Ismail, Mohamed
    Abboud, Yazan
    Pyrsopoulos, Nikolaos
    Kim, Hyunseok
    Hajifathalian, Kaveh
    Al-Khazraji, Ahmed
    HEPATOLOGY, 2024, 80 : S587 - S588
  • [45] Time-trends of fibrosis and steatosis in metabolic dysfunction-associated steatotic liver disease (MASLD): a retrospective cohort analysis
    Arora, Umang
    Biswas, Sagnik
    Dwarkanathan, Vignesh
    Sheikh, Sabreena
    Agarwal, Ayush
    Aggarwal, Arnav
    Mehta, Shubham
    Shalimar, Shalimar
    JOURNAL OF HEPATOLOGY, 2024, 80 : S506 - S506
  • [46] Cutting edge: ferroptosis in metabolic dysfunction-associated steatotic liver disease (MASLD) pathogenesis and therapy
    El-Sehrawy, Amr Ali Mohamed Abdelgawwad
    Rashid, Teeba Ammar
    Ullah, Muhammad Ikram
    Uthirapathy, Subasini
    Ganesan, Subbulakshmi
    Singh, Abhayveer
    Devi, Anita
    Joshi, Kamal Kant
    Jasim, Ahmed Salman
    Kadhim, Abed J.
    FUNCTIONAL & INTEGRATIVE GENOMICS, 2025, 25 (01)
  • [47] Visceral Fat and Diabetes: Associations With Liver Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease
    Kumar, Ashish
    Arora, Anil
    Sharma, Praveen
    Jan, Shayesta
    Ara, Ishrat
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2025, 15 (01)
  • [48] The use of ELF test, FIB-4 and sequential algorithms to screen the Type 2 Diabetes Mellitus (T2DM) population for advanced fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
    Pei, Yiying
    Sng, Wei Kwan
    Quah, Joanne Hui Min
    Liu, Jin
    Chong, Bee Yen
    Lee, Hwee Khim
    Wang, Xue Fei
    Tan, Ngiap Chuan
    Chang, Jason Pik Eu
    Tan, Hong Chang
    Bee, Yong Mong
    Goh, George Boon Bee
    JOURNAL OF HEPATOLOGY, 2024, 80 : S525 - S525
  • [49] The Impact of Japanese Dietary Patterns on Metabolic Dysfunction-Associated Steatotic Liver Disease and Liver Fibrosis
    Sasada, Takafumi
    Iino, Chikara
    Sato, Satoshi
    Tateda, Tetsuyuki
    Igarashi, Go
    Yoshida, Kenta
    Sawada, Kaori
    Mikami, Tatsuya
    Nakaji, Shigeyuki
    Sakuraba, Hirotake
    Fukuda, Shinsaku
    NUTRIENTS, 2024, 16 (17)
  • [50] Novel insights of phenylalanine in Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD) and cardiovascular complications
    Liu, J.
    Chen, Y.
    Qian, J.
    Cui, R.
    Demirkan, A.
    Zheng, Y.
    EUROPEAN HEART JOURNAL, 2024, 45